Showing 923 articles by Gus Cairns

Filters Content type: News, About HIV Author: Gus Cairns

Gus joined the editorial team in 2009 and has previously edited HIV Treatment Update and Preventing HIV. He currently focuses on the PrEP in Europe Initiative and on news reporting.

PrEP programmes & uptake

Improving on a good start: Scotland examines its first four years of PrEP

News
29 April 2021
PrEP programmes & uptake

England's big PrEP implementation trial releases its enrolment data: young people under-represented

News
23 April 2021
Access to healthcare

Testing homeless people during COVID-19 identifies several new HIV cases, especially in Black people

News
21 April 2021
Injectable & long-acting HIV treatment

Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa

News
16 April 2021
Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

News
16 March 2021
Finance & funding

To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP

News
15 March 2021
PrEP science

Interactions between PrEP and gender-affirming hormone therapy A research briefing

About HIV
March 2021
PrEP science

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

News
10 March 2021
Injectable & long-acting PrEP

Reformulated islatravir implant should provide PrEP for over a year

News
9 March 2021
PrEP

Sex, PrEP and HIV in trans and non-binary people A research briefing

About HIV
March 2021
The search for an HIV prevention vaccine

Where next for HIV vaccines and antibody therapies?

News
11 February 2021
PrEP programmes & uptake

African studies explore reasons to start, stick with or stop PrEP

News
8 February 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
Antibody-based prevention

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

News
27 January 2021
PrEP policies & guidelines

European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do

News
27 January 2021
PrEP programmes & uptake

Bacterial STI rates rose in the year before starting PrEP, but not during PrEP, Australian study finds

News
20 January 2021
People & personal stories

Anthony Fauci: “I don’t do this because I’m a hero. I do it because it’s necessary.”

News
14 January 2021
PrEP policies & guidelines

Is reducing anxiety a legitimate indication for PrEP in itself?

News
7 January 2021
Undetectable viral load & treatment as prevention

Undetectable viral load and transmission – information for HIV-negative people

About HIV
November 2020
Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

News
13 November 2020
Hepatitis & HIV

European HIV doctors conduct their first-ever region-wide audit of services

News
11 November 2020
Quality of life

Living with HIV is still a burden, Dutch gay and bisexual men tell researchers

News
3 November 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Access to healthcare

European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe

News
12 October 2020